Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) 17 PATIENT COUNSELING INFORMATION
(rocuronium bromide)
17 PATIENT COUNSELING INFORMATION
Obtain information about your patient's medical history, current medications, any history of hypersensitivity to rocuronium bromide or other neuromuscular blocking agents. If applicable, inform your patients that certain medical conditions and medications might influence how rocuronium bromide works.
In addition, inform your patient that severe anaphylactic reactions to neuromuscular blocking agents, including rocuronium bromide, have been reported. Since allergic cross-reactivity has been reported in this class, request information from your patients about previous anaphylactic reactions to other neuromuscular blocking agents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA 
LAB-1239-4.0
Find Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) medical information:
Find Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) medical information:
Rocuronium bromide (NDC 0409-9558-05 and 0409-9558-10) Quick Finder
Health Professional Information
17 PATIENT COUNSELING INFORMATION
17 PATIENT COUNSELING INFORMATION
Obtain information about your patient's medical history, current medications, any history of hypersensitivity to rocuronium bromide or other neuromuscular blocking agents. If applicable, inform your patients that certain medical conditions and medications might influence how rocuronium bromide works.
In addition, inform your patient that severe anaphylactic reactions to neuromuscular blocking agents, including rocuronium bromide, have been reported. Since allergic cross-reactivity has been reported in this class, request information from your patients about previous anaphylactic reactions to other neuromuscular blocking agents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
LAB-1239-4.0
Health Professional Information
17 PATIENT COUNSELING INFORMATION
17 PATIENT COUNSELING INFORMATION
Obtain information about your patient's medical history, current medications, any history of hypersensitivity to rocuronium bromide or other neuromuscular blocking agents. If applicable, inform your patients that certain medical conditions and medications might influence how rocuronium bromide works.
In addition, inform your patient that severe anaphylactic reactions to neuromuscular blocking agents, including rocuronium bromide, have been reported. Since allergic cross-reactivity has been reported in this class, request information from your patients about previous anaphylactic reactions to other neuromuscular blocking agents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
LAB-1239-4.0
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.